"Filing this nonprovisional patent signifies our passage to the next phase in the development of these cannabis-based anti-inflammatory compounds, which have the potential to alleviate patient suffering," explains Dr. Andrea Small Howard, Chief Science Officer of GB Sciences, Inc. "We look forward to ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment